Intrexon | XON - Stock


Intrexon reported $287K in Stock for its fiscal quarter ending in December of 2022.





Stock Change Date
Amgen USD 6.22B 121M Dec/2025
Anika Therapeutics USD 18.79M 2.5M Dec/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
AstraZeneca USD 6.59B 126M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Incyte USD 101.06M 17.61M Dec/2025
Intrexon USD 287K 68K Dec/2022
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 9.13M 2.77M Dec/2025
MacroGenics USD 7.91M 840K Dec/2025
MannKind USD 35.31M 8.34M Dec/2025
Merck USD 6.44B 157M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Thermo Fisher Scientific USD 5.43B 320M Dec/2025
Veracyte USD 20.55M 219K Dec/2025